Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and …

M Perera, N Papa, M Roberts, M Williams, C Udovicich… - European urology, 2020 - Elsevier
Context Accurate staging of high-risk localised, advanced, and metastatic prostate cancer is
becoming increasingly more important in guiding local and systemic treatment. Gallium-68 …

Sensitivity, specificity, and predictors of positive 68Ga–prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic …

M Perera, N Papa, D Christidis, D Wetherell… - European urology, 2016 - Elsevier
Context Positron emission tomography (PET) of 68 Ga-labelled prostate-specific membrane
antigen (68 Ga-PSMA) is an emerging imaging modality introduced to assess the burden of …

Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial

WP Fendler, J Calais, M Eiber, RR Flavell… - JAMA …, 2019 - jamanetwork.com
Importance In retrospective studies, 68 Ga-PSMA-11 positron emission tomographic (PET)
imaging improves detection of biochemically recurrent prostate cancer compared with …

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0

WP Fendler, M Eiber, M Beheshti, J Bomanji… - European journal of …, 2017 - Springer
The aim of this guideline is to provide standards for the recommendation, performance,
interpretation and reporting of 68 Ga-PSMA PET/CT for prostate cancer imaging. These …

[HTML][HTML] Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients

A Afshar-Oromieh, T Holland-Letz, FL Giesel… - European journal of …, 2017 - Springer
Purpose Since the clinical introduction of 68 Ga-PSMA-11 PET/CT, this imaging method has
rapidly spread and is now regarded as a significant step forward in the diagnosis of …

Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls

MS Hofman, RJ Hicks, T Maurer, M Eiber - Radiographics, 2018 - pubs.rsna.org
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein that is
overexpressed in prostate cancer. Radiolabeled small molecules that bind with high affinity …

Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA PET/CT in prostate cancer patients who have rising PSA after curative treatment and are …

JJ Morigi, PD Stricker, PJ van Leeuwen… - Journal of nuclear …, 2015 - Soc Nuclear Med
In prostate cancer with biochemical failure after therapy, current imaging techniques have a
low detection rate at the prostate-specific antigen (PSA) levels at which targeted salvage …

Metaanalysis of 68Ga-PSMA-11 PET accuracy for the detection of prostate cancer validated by histopathology

TA Hope, JZ Goodman, IE Allen, J Calais… - Journal of Nuclear …, 2019 - Soc Nuclear Med
68Ga-PSMA-11 PET is used to stage patients with prostate cancer. We performed an
updated metaanalysis that separates imaging at the time of diagnosis and at the time of …

68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour

C Uprimny, AS Kroiss, C Decristoforo, J Fritz… - European journal of …, 2017 - Springer
Purpose Prostate cancer (PC) cells typically show increased expression of prostate-specific
membrane antigen (PSMA), which can be visualized by 68 Ga-PSMA-11 PET/CT. The aim of …

[HTML][HTML] 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography for prostate cancer: a systematic review and …

FE von Eyben, M Picchio, R von Eyben, H Rhee… - European urology …, 2018 - Elsevier
Context 68 Gallium prostate-specific membrane antigen (PSMA) ligand 68 Ga-HBED-CC-
PSMA (68 Ga-PSMA) is a promising radiotracer for positron emission tomography …